InsidersTradesSigma
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by Shabahang Shahrokh, Directeur de l'Innovation. Director active across 1 company, notably Aditx Therapeutics, Inc.. In total, 4 filings have been recorded. Breakdown: 4 buys · 0 sell. Total volume traded: €3k. Activity tracked since 25 May 2021. The latest transaction was filed on 1 June 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
4 of 4 declarations
Shabahang Shahrokh is the Chief Innovation Officer at Aditx Therapeutics, Inc. In this role, he is responsible for leading innovation initiatives and developing new products. His expertise is crucial for the organization's growth.